The Relationship between Extracellular Volume Compartments and Matrix Metalloproteinases-2 in Left Ventricular Remodeling after Myocardial Infarction.

Autor: Eyyupkoca F; Departamento de Cardiologia, Dr. Nafiz Korez Sincan State Hospital, Ankara - Turquia., Eyerci N; Departamento de Biologia Médica, Kafkas University Faculty of Medicine, Kars - Turquia., Altintas MS; Departamento de Cardiologia, Istanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul - Turquia., Felekoglu MA; Departamento de Cardiologia, Atakent Hospital, Yalova - Turquia., Biter HI; Departamento de Cardiologia, Istanbul Haseki Training And Research Hospital, Istanbul - Turquia., Hidayet S; Departamento de Cardiologia, Inonu University Faculty of Medicine, Malatya - Turquia., Sivri S; Departamento de Cardiologia, Kirsehir State Hospital, Kirşehir - Turquia., Demirtas B; Departamento de Cardiologia, Cankiri State Hospital, Cankiri - Turquia., Ates OF; Departamento de Cardiologia, Sakarya University Faculty of Medicine, Sakarya - Turquia.
Jazyk: English; Portuguese
Zdroj: Arquivos brasileiros de cardiologia [Arq Bras Cardiol] 2022 Dec; Vol. 119 (6), pp. 946-957.
DOI: 10.36660/abc.20220061
Abstrakt: Background: Matrix metalloproteinases (MMPs) can affect myocardial extracellular volume (ECV) and its compartments, and this can provide more detailed information about the mechanism of adverse left ventricular (LV) remodeling (AR) after acute myocardial infarction (MI).
Objectives: To investigate the role of changes (Δ) in ECV compartments (matrix volume (MVi) and cell volume (CVi)) in the development of AR after MI, and their relationship with MMP-2 expressions.
Methods: Ninety-two first MI patients who underwent 3 Tesla cardiovascular magnetic resonance imaging performed 2 weeks (baseline) and 6 months post-MI. We measured T1 mapping with MOLLI sequences. ECV was performed post-gadolinium enhancement. ECV and LV mass were used to calculate MVi and CVi. AR was defined as an increase of ≥ 12% in LV end-diastolic volume in 6 months. MMPs were measured using a bead-based multiplex immunoassay system at first day (baseline) and 2 weeks post-MI. P <0.05 was accepted as statistically significant.
Results: Mean ECV and mean MVi baseline levels were higher in AR group compared to without AR group (42.9±6.4 vs 39.3±8.2%, p= 0.037; 65.2±13.7 vs 56.7±14.7 mL/m2, p=0.010; respectively). CVi levels was similar between groups. A positive correlation was found between baseline levels of MMP-2 and baseline levels of ECV (r=0.535, p<0.001) and MVi (r=0.549, p<0.001). Increased ΔMVi levels was independently predictor of AR (OR=1.03, p=0.010). ΔMVi had superior diagnostic performance compared to ΔECV in predicting AR (ΔAUC: 0.215±0.07, p<0.001).
Conclusion: High MVi levels are associated with AR, and ΔMVi was independently predictor of AR. This may be associated with MMP-2 release due to increased inflammatory response.
Databáze: MEDLINE